Metabolic syndrome is associated with an increase of cardiovascular mortality in men

Metabolic syndrome is associated with an increase of cardiovascular mortality in menMetabolic syndrome is associated with an increase of cardiovascular mortality in men Metabolic syndrome (MS) is a recognized factor of cardiovascular risk, but the mechanisms of its effects on cardiovascular and total mortality is still unclear, noted Dr. Hanna-Maaria Lakka and her colleagues from Louisiana state University (Baton Rouge). For more than 10 years (11.6 years), the researchers observed 1209 Finnish middle-aged men. The diagnosis of MS was exhibited in accordance with the criteria of the program NCEP (National Cholesterol Education Program) and who. In the who criteria higher 'critical' level of blood pressure (BP) and low - cholesterol high-density lipoprotein (HDL). MS prevalence ranged from 8.8% 14.2%, depending on the criteria of MS, as well as criteria for abdominal obesity. Regardless of the chosen criteria, men with MS had at least 2.9 times higher risk of death from coronary heart disease than participants without him. When using the who criteria, the presence of MS was associated with increased risk of cardiovascular and total mortality (2.6-3.0 and 1.9-2.1 times, respectively). Criteria NCEP had less predictive value. Link MS and mortality occurred even in the initial absence of cardiovascular disease or diabetes. 'As far as we know, this is the first prospective population-based cohort study linking MS (diagnosed according to current criteria) with total and cardiovascular mortality', say the authors. 'Early detection, treatment and prevention of MS is one of the leading tasks of doctors and health managers. This is especially true now, when the problem of obesity and sedentary lifestyles have become epidemic'. Source: Solvay Pharma.



Похожие статьи

Ваше имя
Ваша почта
Город, область
Рассылка комментариев





Ввести код: